Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors

NCT00471588 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG: Pramipexole, Amisulpride

Sponsor

GlaxoSmithKline